FINWIRES · TerminalLIVE
FINWIRES

Bank of America's Q1 Results Could Support Re-Rating, UBS Says

By

Bank of America (BAC) reported "clean" Q1 earnings per share of $1.11, beating consensus of $1.02 and UBS estimate of $1.03, with the investment firm saying the results could support a re-rating but the upcoming earnings call and guidance will be key for sustained outperformance.

The bank reported deposit costs of 1.99%, beating consensus by 7 basis points. UBS Securities said this is critical as Wells Fargo (WFC) missed on this front, and a differentiated path on deposit rates could be a breakout catalyst for Bank of America.

Investment banking fee of $1.84 billion was in line with consensus and did not have the "beat factor" seen at Goldman Sachs (GS) and JPMorgan (JPM), with advisory, equity capital markets, and debt capital markets all coming in line, according to the note.

Q1 pre-provision net revenue beat of 4% may not be as notable as at Citi (C), JPMorgan, and Goldman Sachs, the brokerage said in a Wednesday note. However, it is meaningful for a stock with an undemanding valuation. This is especially as expenses fell in line with guidance and the company generated 290 basis points of year-over-year operating leverage.

UBS said guidance by the bank is "critical for share performance".

The firm has a buy rating on Bank of America with a price target of $62.

Price: $53.75, Change: $-0.57, Percent Change: -1.05%

Related Articles

Wire

Savara Says FDA Extended Review Period for Molgramostim Inhalation Solution Application

Savara (SVRA) said late Wednesday the US Food and Drug Administration has extended the review period for molgramostim biologics license application in autoimmune pulmonary alveolar proteinosis, a rare lung disease, by three months.The new prescription drug user fee act target action date for the inhalation solution is Nov. 22, the company said.The FDA did not cite any efficacy, safety, or manufacturing concerns, the company said, adding that the FDA determined that the responses to recent information requests represented a significant amendment to the application.

$SVRA
Wire

Euroseas Extends EM Kea Charter for Three Years at Higher Daily Rate

Euroseas (ESEA) extended a charter contract for its feeder containership EM Kea by three years at a gross daily rate of $30,000.The charter is set to begin on July 14 and reflects nearly a 60% increase over the vessel's current rate, the company said Wednesday in a statement.Euroseas expects the charter to generate about $22.5 million in EBITDA over the minimum contracted period.The company's shares fell 2% in after-hours trading.

$ESEA
Wire

Voyager Wins NASA Order for Seventh Private Astronaut Mission to International Space Station

Voyager Technologies (VOYG) said late Wednesday it has signed an order with National Aeronautics and Space Administration for the seventh private astronaut mission to the International Space Station, with a launch planned no earlier than 2028.The mission, dubbed VOYG-1, supports NASA's strategy to shift low-Earth orbit operations to the private sector by enabling commercial partners to deliver human spaceflight services, the company said.

$VOYG